BIOR – American College of Gastroenterology
The only reason this is making it on the Catalyst Calendar is because BIOR has a catalyst within a few weeks of this one (before it). When a company starts […]
The only reason this is making it on the Catalyst Calendar is because BIOR has a catalyst within a few weeks of this one (before it). When a company starts […]
These guys bill themselves as the "Woodstock of Microcap," and have apparently over 200 companies presenting. Here's the problem, they won't let just anybody see the list. We have an […]
Companies with booths: AEON, AMPH, ESE, EVFM, FEMY, INVO, LH, CYRX (owns MVE Biological Solutions), UTRS, MYOV, NAN, NTRA, OGN, PGNY. We did our best to go through all those […]
This event ends on November 1st, and has a million and one companies presenting at it. The full list is below, but the tickers that stand out to us as […]
This Fed Meeting is widely expected to culminate in either a .25% or .5% rise in interest rates. Typically, going into the meeting, traders are extra jittery, and volatility tends […]
This event has a very specific audience. If you have read previous blurbs about the Catalyst Calendar Events, we try to focus in on events where the audience is likely […]
This event lasts until the 5th, and while it is focused on Nephrology, there are a lot of companies attending, and many of the companies have smaller floats, higher volatility, […]
This is a vote on a Reverse Split. However, there was going to a be a vote on increasing the share count (ie a Shelf offering), but that was withdrawn […]
This is a meeting about converting debt into new debt. Event traders would be focused on this, but since it is such a low float, institutions positioning before the vote […]
This event lasts until the 10th and is another one where the Event Traders, who look to capitalize on a potential market reaction to a company presentation might have a […]
This is more of a "Fireside Chat" according to the PR, but it singles out one company and gives them a platform to discuss their positive developments with a new […]
The data being presented is Phase 1/2 data, which is very pre-liminary, which in this case is a good thing. Catalyst traders love when "rumors" can take over the psychology […]